Keywords: merck, present, positive, results, metastases, therapy, drug

Merck to present positive results for metastases therapy

Article | 26 May 2008

Print This

US drug major Merck & Co will present positive results for a Phase II trial on its odanacatib (formerly MK-0822) candidate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in